SIG Brokerage’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
9,300
+7,100
+323% +$7.25M 0.22% 84
2026
Q1
$2.02M Buy
2,200
+1,000
+83% +$1.01M 0.05% 268
2025
Q4
$1.29M Sell
1,200
-2,000
-63% -$1.91M 0.04% 299
2025
Q3
$2.44M Sell
3,200
-1,800
-36% -$1.34M 0.07% 220
2025
Q2
$3.9M Buy
+5,000
New +$3.89M 0.1% 138

Other funds holding LLY

SIG Brokerage's LLY Position: Q2 2026 in Review

SIG Brokerage reduced its Eli Lilly (LLY) stake by 57% in Q2 2026, selling an estimated $2.03M and leaving 1,487 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #358.

SIG Brokerage first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.2M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SIG Brokerage held 1,487 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • SIG Brokerage sold 1,988 Eli Lilly shares in Q2 2026, an estimated $2.03M.
  • Eli Lilly made up 0.03% of SIG Brokerage's portfolio in Q2 2026, its #358 holding.
  • SIG Brokerage first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • SIG Brokerage's Eli Lilly position peaked at $3.2M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.